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Abstract
Introduction: Major trauma is characterized by an overwhelming pro-inflammatory response and an
accompanying anti-inflammatory response that lead to a state of immunosuppression, as observed after septic
shock. Diminished monocyte Human Leukocyte Antigen DR (mHLA-DR) is a reliable marker of monocyte
dysfunction and immunosuppression. The main objective of this study was to determine the relation between
mHLA-DR expression in severe trauma patients and the development of sepsis.
Methods: We conducted a prospective observational study over 23 months in a trauma intensive care unit at a
university hospital. Patients with an Injury Severity Score (ISS) over 25 and age over 18 were included. mHLA-DR
was assessed by flow cytometry protocol according to standardized protocol. Mann-Whitney U-test for continuous
non-parametric variables, independent paired t test for continuous parametric variables and chi-square test for
categorical data were used.
Results: mHLA-DR was measured three times a week during the first 14 days. One hundred five consecutive
severely injured patients were monitored (ISS 38 ± 17, SAPS II 37 ± 16). Thirty-seven patients (35%) developed
sepsis over the 14 days post-trauma. At days 1-2, mHLA-DR was diminished in the whole patient population, with
no difference with the development of sepsis. At days 3-4, a highly significant difference appeared between septic
and non-septic patients. Non- septic patients showed an increase in mHLA-DR levels, whereas septic patients did
not (13,723 ± 7,766 versus 9,271 ± 6,029 antibodies per cell, p = .004). Most importantly, multivariate logistic
regression analysis, after adjustment for usual clinical confounders (adjusted OR 5.41, 95% CI 1.42-20.52), revealed
that a slope of mHLA-DR expression between days1-2 and days 3-4 below 1.2 remained associated with the
development of sepsis.
Conclusions: Major trauma induced an immunosuppression, characterized by a decrease in mHLA-DR expression.
Importantly, after multivariate regression logistic analysis, persistent decreased expression was assessed to be in
relation with the development of sepsis. This is the first study in trauma patients showing a link between the lack
of immune recovery and the development of sepsis on the basis of the standardized protocol. Monitoring immune
function by mHLA-DR measurement could be useful to identify trauma patients at a high risk of infection.
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The global burden of death and disability due to injuries
is increasing, especially in patients younger than 40
years old [1]. In the course of supportive management,
injured patients often develop sepsis, which is the most
frequent cause of complications and death following
severe injury [2]. Immunosuppression has emerged
recently as a risk factor for sepsis in trauma patients
[3,4]. It is now well established that any situation of
injury or stress can induce a systemic inflammatory
response that is often followed by an anti-inflammatory
response [5-7]. This compensatory feedback mechanism,
which maintains inflammatory immune homeostasis, is
believed to lower natural defenses against pathogens and
contribute to a state of immunosuppression [8-10] and
is known to occur in cases of sepsis, septic shock, burns,
stroke, and injury and in patients undergoing major sur-
gery. Such alterations might be directly responsible for a
detrimental outcome in trauma patients and for lower-
ing the resistance to nosocomial infections in patients
who have survived initial resuscitation [7-9,11].
In the absence of specific clinical signs of immune
function in intensive care patients, biomarkers of immu-
nosuppression are clearly highly desirable. Diminished
expression of human leukocyte antigen DR expression
on circulating monocytes (mHLA-DR) is widely
accepted as a reliable indicator of immunosuppression
in critically ill patients [12-14]. Some work has been
devoted to trauma patients, but for the most part, these
preliminary studies were performed 10 years ago (that
is, before the advent of the last advanced trauma life
support [ATLS] protocol for the management of multi-
ple-injury patients). Early findings on mHLA-DR were
based on limited numbers of patients and used non-
standardized flow cytometry protocols [15-20]. The pur-
pose of this study was to investigate mHLA-DR expres-
sion on the basis of the standardized protocol and to
assess this expression as a predictive factor of infection
in a multivariate analysis.
In the study described here, mHLA-DR expression
was measured according to recently established flow
cytometry protocols in a group of severely injured
patients. The main objective of the study was to assess
whether a low mHLA-DR expression might be a good
predictor of infection in such patients.
Materials and methods
Patients’ inclusion
This prospective observational study was carried out
over a 15-month period (July 2008 to September 2009).
The protocol was reviewed by the institutional ethics
committee, which waived the need for informed consent
because the study was observational and involved sam-
pling of very small quantities of blood (100 μL). The
purpose of the study was explained to the patients or
members of their families. Samples were collected from
residual blood after completion of routine follow-up.
Inclusion criteria were an Injury Severity Score (ISS)
[21,22] of more than 25 and admission to the intensive
care unit (ICU). Clinical exclusion criteria were age of
less than 18 years, ISS of less than 25, chronic corticos-
teroid therapy, and death in the first 48 hours after
admission. Patients admitted on a Saturday were
excluded because mHLA-DR cannot be measured on
day 1 or 2 (blood samples were not collected on Satur-
days or Sundays, when the laboratory did not operate).
All patients admitted were followed up with prospec-
tively until day 14 by daily clinical examination and bio-
logical tests. During follow-up, clinical and biological
data were collected. The data collection comprised
demographic characteristics (age and gender), infection
characteristics (source, microorganisms identified, delay
between trauma, and onset of sepsis), and outcome at
28 days (death or survival). Therapeutic data were also
collected (a) on admission to the trauma room (the
need for inotropic or vasoactive support and blood pro-
ducts [red blood cells, fresh frozen plasma, platelets, and
albumin] and their quantities used to sustain a mean
arterial pressure [MAP] up to 70 mm Hg [or 90 mm Hg
in the case of cranial trauma], and the type and quantity
of prophylactic antibiotics) and (b) during support
(number of ventilator days, quantity and type of vasoac-
tive support and of blood products, and use of massive
transfusion, which was defined as more than 10 units of
blood [23] or the replacement of the patient’st o t a l
blood volume [24] over a 24-hour period). Creatinine,
lactate concentration, and abnormal biphasic pulse
transmittance waveform (BPW) were measured daily.
Three clinical scores were recorded: ISS on admission
(range of 0 to 75), initial severity of disease as assessed
by the new Simplified Acute Physiology Score II (SAPS
II) (range of 0 to 164) [25], and the Sepsis-related
Organ Failure Assessment (SOFA) score (range of 0 to
24) on admission and every day during follow-up [26].
Severe brain and thoracic injury, which are well estab-
lished as risk factors for sepsis development, were also
taken into account [22].
Sepsis definition
The American College of Chest Physicians/Society of
Critical Care Medicine Consensus Conference [27] defi-
nition of sepsis was used for this study, namely the pre-
s e n c eo fa ni d e n t i f i a b l es i t eo fi n f e c t i o na n de v i d e n c eo f
a systemic inflammatory response on the basis of at
least two of the following criteria: (a) body temperature
of greater than 38°C or of less than 36°C, (b) heart rate
of greater than 90 beats per minute, (c) respiratory rate
of greater than 20 breaths per minute or
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sure of carbon dioxide (PaCO2)o fl e s st h a n3 2m mH g
(less than 4.3 kPa), and (d) a white blood cell count of
greater than 12,000 cells/mm
3 or of less than 4,000
cells/mm
3 o rt h ep r e s e n c eo fm o r et h a n1 0 %i m m a t u r e
neutrophils. The onset of sepsis was defined, as recom-
mended by the Consensus Conference [27], as the day
on which the site of infection was identified. The final
diagnosis of sepsis was retrospectively established by
two experts assessing the complete medical data and
not involved in case management. Diagnoses of pneu-
monia and urinary infection were established according
to the guidelines of the American Thoracic Society and
the Infectious Diseases Society of America [28] and of
the Centers for Disease Control [29], respectively. Phy-
sicians were not informed of mHLA-DR results. BPW
was also determined as it may be used as an indicator
of sepsis development [30-32].
Blood sampling and flow cytometric analysis
Ethylenediaminetetraacetic acid (EDTA)-anticoagulated
blood samples were collected at 8 a.m. every 2 days
after injury (on Mondays, Wednesdays, and Fridays)
(that is, at days 1 and 2, days 3 and 4, days 5 and 6,
days 7 and 8, days 9 and 10, and days 11 and 12). Flow
cytometric (EPICS XL; Beckman Coulter, Inc., Hialeah,
FL, USA) expression of monocyte HLA-DR was assessed
on arterial, venous, or capillary blood. Blood samples
were stored immediately at 4°C and stained within 2
hours after collection, in accordance with the standardi-
zation recommendations for mHLA-DR measurement
[33,34]. Staining and cell acquisition were undertaken as
described in the European standardized protocol.
Monoclonal antibodies and their respective isotype con-
trols were used according to the manufacturers’ recom-
mendations: fluorescein isothiocyanate (FITC)-labeled
anti-CD14 (10 μL; Immunotech, Marseille France) and
phycoerythrin (PE)-labeled anti-HLA-DR (20 μL; BD
Pharmingen, San Diego, CA, USA) per 100 μLo fw h o l e
blood. Monocytes were characterized on the basis of
their CD14 expression. Results were expressed as the
number of anti-HLA-DR antibodies per cell (AB/C)
(normal >15,000), which is correlated with the number
of HLA-DR molecules expressed on each monocyte
[33].
Because sepsis alone can amplify a drop in mHLA-DR
expression, mHLA-DR expression data were excluded
from the analysis after the onset of sepsis, thereby pre-
cluding calculation of a difference in mHLA-DR expres-
sion between septic and non-septic patients at days 7
and 8, 9 and 10, and 11 and 12 (because of insufficient
numbers of values for statistical analysis).
Statistical analysis
The Kolmogorov-Smirnov test was used to verify all
data for normality. Baseline characteristics were
described by frequency, median and interquartile range
(IQR), or (where appropriate) mean ± standard devia-
tion. Patients were separated into two groups: those
who developed sepsis and those who did not. The
groups were compared using the Mann-Whitney U test
for continuous non-parametric variables, the indepen-
dent paired t test for continuous parametric variables,
and the chi-square test for categorical data. mHLA-DR
expression was stratified according to the best threshold
chosen using the Youden index. Receiver operating
characteristic (ROC) curves and the areas under the
curve were calculated for the slope in mHLA-DR
between days 1 and 2 and days 3 and 4. Univariate and
multivariate logistic regression analyses were used to
identify variables associated with the risk of infection
and assessed by odds ratios (ORs) and 95% confidence
intervals (CIs). A P value of less than 0.05 was taken as
the significance level. The Bonferroni correction was
used to avoid spurious results from the multiple statisti-
cal tests performed simultaneously. The alpha values for
three or six tests were 0.016 and 0.008, respectively.
MedCalc software version 9.6.4.0 (MedCalc Software
bvba, Mariakerke, Belgium) was used to perform the sta-
tistical analyses.
Results
Patients’ characteristics
A total of 536 consecutive patients in the early stages of
trauma were admitted to the trauma room between July
2008 and May 2010. One hundred five of these patients
met the inclusion criteria of the study (Figure 1). One
hundred thirty patients were excluded because they had
Figure 1 Flowchart of inclusion criteria of the study.I S S ,I n j u r y
Severity Score.
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reasons: no available rooms in our unit or the need for
specific care such as aortic rupture isthmus or brain sur-
gery (following severe brain injury). Table 1 shows the
baseline characteristics on these 105 patients. SAPS II
was significantly higher in septic patients (P < 0.05)
than in non-septic patients as were the SOFA scores
every day during follow-up and the incidence of severe
brain injury. There were no statistical differences of the
ISS or the incidence of severe thoracic injury between
the two groups. In the emergency room, administration
of vasoactive drug to maintain an MAP of up to 65 mm
Hg and administration of prophylactic antibiotics were
not different. Frequency of massive transfusion and the
overall quantity of transfused blood were not different
for the sepsis and non-sepsis groups over the first 2
post-trauma days. There was a higher proportion of
patients under vasoactive drug during the first 2 days in
the septic group (P = 0.0004). During follow-up, no dif-
ference in renal function (assessed by plasma creatinine
concentration) or in lactate concentration was observed.
Septic patients required mechanical ventilation more
often and for longer periods of time than non-septic
patients did (P < 0.0001). Six patients died (three from
septic shock and three from cardiogenic shock), and
there were no statistical differences between the two
groups.
Incidence of sepsis
Thirty-seven patients developed sepsis during follow-up.
Pneumonia was the more frequent infection (n = 30),
followed by urinary tract infection (n =7 ) .C a u s a t i v e
bacteria were fairly evenly distributed between Gram-
positive (n = 14) and Gram-negative (n = 21) organisms.
Table 1 Clinical patients’ characteristics
Parameters Overall population
n = 105
Septic
n = 37 (35%)
Non-septic
n = 68 (65%)
P value
Age, years 38.1 ± 16.9 34.8 ± 15.6 39.9 ± 17.5 0.15
a
Male, % (n) 72.4% (n = 76) 78.4% (n = 29) 69.1% (n = 47) 0.43
b
ISS 37.1 ± 9.9 38.7 ± 8.9 36.2 ± 10.4 0.20
a
Severe brain injury, % (n) 41% (n = 43) 59% (n = 22) 31% (n = 21) 0.008
b
Severe thoracic injury, % (n) 72% (n = 76) 65% (n = 24) 76% (n = 52) 0.30
b
SAPS II 36.9 ± 15.6 43 ± 15.4 33.5 ± 14.8 0.003
a
Delay for MAP >65 mm Hg, minutes 0 (0 to 0.25) 0 (0 to 16.25) 0 (0 to 0) 0.14
c
Need for vasoactive support in emergency room, % (n) 24% (n = 25) 35% (n = 13) 18% (n = 12) 0.077
b
Prophylactic antibiotics administrated in emergency room, % (n) 42% (n = 44) 35% (n = 13) 46% (n = 31) 0.41
b
SOFA score
D1 4 (2 to 7) 6 (4 to 9.2) 3 (2 to 5) 0.0001
c
D2 4 (2 to 6) 6 (3.75 to 9.25) 2.5 (1 to 5) <0.0001
c
D3 3 (1 to 5) 7 (3 to 9.25) 2 (1 to 3) <0.0001
c
D4 2 (1 to 5) 5 (2 to 8) 2 (1 to 3) <0.0001
c
D5 2 (1 to 4) 4 (1.75 to 7.25) 1 (1 to 2) <0.0001
c
D6 1 (1 to 3) 3 (1 to 7) 1 (1 to 2) <0.0001
c
mHLA-DR levels, antibodies per cell
D1 and 2 11,371 ± 4,870 11,753 ± 4,291 11,177 ± 5,169 0.62
a
D3 and 4 12,224 ± 7,501 9,271 ± 6,029 13,723 ± 7,766 0.004
a
D5 and 6 15,623 ± 9,123 11,707 ± 6,004 16,602 ± 9535 0.05
a
Variations in mHLA-DR, antibodies per cell
D3 and 4/D1 and 2 1.25 ± 0.57 0.83 ± 0.43 1.44 ± 0.53 <0.0001
a
D5 and 6/D3 and 4 1.37 ± 1.11 1.32 ± 0.82 1.38 ± 1.18 0.83
a
Deaths at day 28, % (n) 6% (n =6 ) 8 %( n =3 ) 4 %( n = 3) 0.73
b
Mechanical ventilation, % (n) 66% (n = 69) 89% (n = 33) 53% (n = 36) 0.0004
b
Duration of mechanical ventilation, days 6 (3 to 11) 9 (6.75 to 19) 3 (2 to 5.5) <0.0001
c
Massive transfusion required, % (n) 29% (n = 31) 35% (n = 13) 26% (n = 18) 0.48
b
Volume of transfusion, mL 900 (0 to 2,850) 1,200 (0 to 3,500) 0 (0 to 2,700) 0.067
c
Shock (need for vasoactive drug on D1 and 2), % (n) 33% (n = 35) 57% (n = 21) 21% (n = 14) 0.0004
b
Length of stay in ICU, days 9 (6 to 15) 15 (10 to 24.25) 7 (5 to 11) <0.0001
c
Parametric variables are expressed as mean ± standard deviation, and non-parametric variables are expressed as median (interquartile range) or frequencies.
aIndependent samples t test;
bchi-square test;
cMann-Whitney test. D, days; ICU, intensive care unit; ISS, Injury Severity Score; MAP, mean arterial pressure; mHLA-
DR, monocyte human leukocyte antigen-DR; SAPS II, Simple Acute Physiology Score II; SOFA, Sepsis-related Organ Failure Assessment.
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positive and -negative). The median interval between
trauma and onset of sepsis was 4 days (3 to 6.25).
Monitoring of mHLA-DR expression
At day 2, mHLA-DR expression was diminished in all
105 patients (Figure 2 and 3a). At days 1 and 2, mHLA-
DR expression showed no statistically significant differ-
ence between septic and non-septic patients (Table 1
and Figure 3b). At days 3 and 4, mHLA-DR expression
had risen in non-septic patients but remained low in
septic patients (13,723 ± 7,766 AB/C versus 9,271 ±
6,029 AB/C; P = 0.004) (Figure 3b). At days 5 and 6,
septic patients still tended to exhibit lower mHLA-DR
expression than non-septic patients, but the difference
failed to reach statistical significance.
G i v e nt h ew i d ef l u c t u a t i o no fm H L A - D Re x p r e s s i o n
data, ratios were calculated between values for two
points in time, namely days 3 and 4/days 1 and 2 and
days 5 and 6/days 3 and 4. The slope of mHLA-DR
expression at days 3 and 4 showed a highly significant
statistical difference between non-septic and septic
patients (1.44 ± 0.53 versus 0.83 ± 0.43, respectively; P <
0.0001) (Table 1). We next established an ROC analysis
(Figure 4). The area under the curve was 0.80 (P = 0.05,
95% CI 0.69 to 0.88). ROC curve analysis for delta
mHLA-DR provided a 1.2 variation in mHLA-DR
expression (days 3 and 4/days 1 and 2) as the best cutoff
value to discriminate between septic and non-septic
patients. At that threshold, the test had an 83% sensitiv-
ity, a 61% specificity, a 42% positive predictive value,
and an 87% negative predictive value. At days 5 and 6,
no significant difference was observed in mHLA-DR
expression or in the mHLA-DR slope (days 5 and 6/
days 3 and 4) between the two patient groups.
Multivariate logistic regression analysis indicated, after
adjustment for other confounding factors, that an
mHLA-DR ratio of days 3 and 4/days 1 and 2 less than
or equal to 1.2 was associated with sepsis to a highly
significant degree (adjusted OR 5.41, 95% CI 1.42 to
20.52) (Table 2).
Discussion
Severe injury is characterized by a systemic inflamma-
tory response syndrome involving activation of several
cellular systems and the overwhelming production, by
the innate immune system, of proinflammatory cyto-
kines and other inflammatory mediators. It is subse-
quently followed by a compensatory anti-inflammatory
response syndrome [35,36]. This negative feedback
mechanism has a protective effect over the first few
hours after trauma but may become harmful if it
(a) Whole blood (b) Gated on CD14+ monocytes
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Figure 2 Monocyte human leukocyte antigen-DR (HLA-DR) measurement by flow cytometry. (a) Monocyte identification in whole blood.
An ungated leukocyte biparametric representation on the basis of side scatter characteristics (SSC, y-axis) and CD14 expression (FITC-CD14, x-
axis) is shown. CD14-expressing population is easily distinguishable as gating region ‘CD14+ monocytes’. (b) Gated cells from ‘CD14+ monocytes’
in (a) are expressed on the basis of HLA-DR expression (monoparametric histogram, PE-HLA-DR). The black histogram depicts isotype control,
whereas the gray one represents patient expression (illustrative example). Results are obtained as means of fluorescence intensities (MFI) and
then are transformed into number of antibodies per cell (AB/C). FITC, fluorescein isothiocyanate; PE, phycoerythrin.
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Page 5 of 10persists. Considerable clinical and experimental evidence
indicates that in such patients a number of immune
functions are rapidly altered. Monocyte alterations, for
example, can decrease phagocytosis, inflammatory cyto-
kine expression, and antigen presentation because of the
loss of mHLA-DR expression. Lymphocyte anergy and
apoptosis can ensue [3,37-39]. These changes together
may increase susceptibility to infection, which in turn
could provoke multiple organ failure and death.
Diminished mHLA-DR expression has been proposed
as a reliable biomarker of immunosuppression in ICU
patients. Today, it is the most reliable marker and is
used in most of the studies about ICU-acquired immu-
nosuppression. More specifically, it has been shown to
be a predictor of septic complications in several condi-
tions, including surgical interventions, sepsis, burns,
stroke, and pancreatitis [11,40-48]. Immunosuppression
has long been postulated as a concomitant of trauma
[37,49,50]. In regard to mHLA-DR, the pioneering work
of Polk and colleagues [50] reported in 1986 revealed an
association between the development of sepsis and low
mHLA-DR expression. Subsequently, mHLA-DR expres-
sion was assessed as a predictor of sepsis in several ser-
ies of severely injured patients [15,17,18,20,39,51-53]. A
major limitation of these studies is that they were con-
ducted over a 20-year period, during which time case
management and methodologies for measurement of
mHLA-DR expression have evolved, thereby complicat-
ing interpretation and comparison of the findings of
these studies.
In the present cohort, incidence of sepsis was 35% and
t h em o r t a l i t yr a t ef o rt h ee n t i r es t u d yw a s6 % .T h o u g h
apparently high, these values are in concordance with
those of a previous epidemiologic study by Osborn and
colleagues [2], in which incidence rates of sepsis were
42% for moderate injury (defined as an ISS of between
15 and 29) and 39% for severe injury (ISS of up to 30).
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Figure 3 Time course of monocyte human leukocyte antigen-
DR (mHLA-DR) expression in trauma patients. Mean and
standard deviation are presented. Results are expressed as numbers
of anti-mHLA-DR antibodies bound per cell (AB/C). The independent
paired t test was used for comparison between groups. *P < 0.01.
(a) mHLA-DR expression in the whole trauma population. (b)
mHLA-DR expression in patients with (gray bars) or without (white
bars) sepsis.
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Figure 4 Receiving operating curve of variation of monocyte
human leukocyte antigen-DR expression ratio (days 3 and 4/
days 1 and 2) expressed as antibodies per cell for predicting
sepsis. Area under curve was 0.80 (P = 0.05, 95% confidence
interval 0.69 to 0.88). The best threshold (that is, which maximized
sensitivity and sensibility) was 1.2. For a cutoff of 1.2, positive
predictive value was 42% and negative predictive value was 87%.
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reported a low sepsis incidence, but most of the patients
presented with mild injury (ISS of less than 15: 67.7%)
and no brain injury [54], the latter of which is known to
be a risk factor for developing pneumonia [55-58]. In
our cohort, septic patients presented more trauma brain
injury than the non-septic patients did, and this is in
concordance with the literature.
T h ep r e s e n ts t u d ys h o w e da no v e r a l lr e d u c t i o ni n
mHLA-DR expression in trauma patients. Most impor-
tantly, in injured patients with an uneventful outcome,
mHLA-DR expression returned to normal within a
week. In contrast, in patients who developed infection,
mHLA-DR levels remained low or fell even lower.
It would appear that the steepness of the slope of
mHLA-DR recovery is a more significant indicator than
the levels attained at a given point in time. Indeed, the
incidence of sepsis was significantly greater in the group
with a slope of less than 1.2 (days 3 and 4/days 1 and
2). This suggests that patients in whom recovery in
mHLA-DR expression did not begin between days 1 and
2 and days 3 and 4 had an increased risk of developing
sepsis. This observation is consistent with recent find-
ings reported by Lukaszewicz and colleagues [59] in sur-
gical patients. Significantly, in the present study,
multivariate logistic regression analysis indicated that
low mHLA-DR expression was independently associated
with the development of sepsis, whereas all the other
parameters included in the analysis (ISS, SAPS II, pre-
sence of a severe brain trauma, and massive transfusion)
were not predictive. A slope of mHLA-DR of less than
1.2 was independently associated with the risk of devel-
oping sepsis, a finding that reflects the possible pivotal
role of immune dysfunction in the increased risk of
infection in trauma patients. In Table 1 some variables
that may seem relevant (like the length of stay in the
ICU and the duration of mechanical ventilation) were
not included in the multivariate analysis, because they
have to be considered as a consequence of the develop-
ment of sepsis and not a risk factor. Moreover, it has to
be considered that the onset of sepsis is early (median
at day 4) and that every patient was still in the ICU at
this time point.
Chest trauma is reported to account for one third of
acute-trauma emergency room admissions, and 30% to
75% of trauma patients have pulmonary contusions [60],
usually as a result of rapid deceleration [61]. The inci-
dence of lung injury seemed to be quite significant in
our study (72%) and is probably due to the severity of
the trauma patients included. However, there were no
differences between the presences of thoracic injury
between infected and non-infected groups. The patho-
physiology of pulmonary contusion includes a strong
inflammatory response in the lung parenchyma, result-
ing in increased alveolocapillary permeability, pulmonary
edema, ventilation/perfusion mismatch, increased pul-
monary shunting, and loss of compliance. As at the sys-
temic level, this local response is followed by an anti-
inflammatory response. Muehlstedt and colleagues [19]
observed not only altered HLA-DR expression on the
surface of alveolar macrophages in the lungs of trauma
patients who developed sepsis but also altered produc-
tion of other cytokines. Local organ immunosuppression
was present and may have been responsible for the
development of nosocomial pneumonia in the injured
patients [19].
As far as the authors can ascertain, this is the first
study, using the standardized test described by the Eur-
opean multicenter study [33] and multivariate analysis,
aimed specifically at evaluating mHLA-DR expression in
a cohort of severe trauma patients. Most previous stu-
dies have been conducted in smaller series of patients
spanning a highly variable spectrum of severity (from
mild to severe trauma) [15-17,58]. Furthermore, these
studies did not include multivariate analysis for assess-
ment of the usual clinical confounders of mHLA-DR
expression levels, nor did they exclude mHLA-DR
expression data following onset of sepsis, as the present
study did (see Materials and methods) in order to avoid
bias from possible amplification by the sepsis itself of
Table 2 Univariate and multivariate logistic regression analysis used to differentiate septic and non-septic patients
Univariate (n = 105) Multivariate (n = 77)
OR 95% CI P value OR 95% CI P value
Sex male Positive 1.62 0.63-4.13 0.3129
Severe brain injury Positive 3.28 1.42-7.56 0.005 2.87 0.95-8.72 0.06
Severe thoracic injury Positive 0.57 0.23-1.37 0.21
ISS ≥40 2.19 0.95-5.06 0.066 2.84 0.88-9.16 0.08
SAPS II ≥37 3.17 1.38-7.32 0.007 2.01 0.67-6.08 0.21
D3 and 4/D1 and 2 mHLA-DR ≤1.2 4.81 1.45-16 0.009 5.41 1.42-20.52 0.013
Massive transfusion Positive 1.5 0.63-3.57 0.35
CI, confidence interval; D, days; ISS, Injury Severity Score; mHLA-DR, monocyte human leukocyte antigen-DR; OR, odds ratio; SAPS II, Simple Acute Physiology
Score II.
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previous studies are not readily comparable, owing to
differences, from one study to another, in the values stu-
died (mainly ‘percentages of positive monocytes’ or
‘mean fluorescence intensity’), which are generally speci-
fic for a given laboratory and therefore defy comparabil-
ity on a wider scale. The European protocol now
recommends expression of the results as numbers of
antibodies per cell, a recommendation that will facilitate
comparison of data obtained by different laboratories.
The present study has a number of limitations. First, it
is a single-center study. The findings clearly need to be
confirmed by a multicenter study. Second, the study
enrolled only 105 patients. Though relatively small, the
series was very homogeneous in terms of severity and
also highly representative of the trauma patient popula-
tion commonly encountered. Finally, mHLA-DR expres-
sion was measured every 2 days after trauma. However,
the mean onset of infection was on day 4; in some
patients, this limited the amount of analyzable mHLA-
DR expression data available before day 4. In subsequent
studies, follow-up of patients should consist of daily
monitoring during the early post-trauma period. Indeed,
one potentially interesting objective of a future study
would be an assessment of the usefulness of daily
mHLA-DR measurements to detect patients at an
increased risk of infection. To pre-empt development of
infection, clinicians could give these patients prophylac-
tic treatment, such as antibiotics [48], immunostimulant
by interferon-gamma [62], or granulocyte-macrophage
colony-stimulating factor, as used in septic shock [35].
Conclusions
Trauma induces a temporary, relative immunosuppres-
sion characterized by diminished mHLA-DR expression.
The pattern of progression of mHLA-DR expression over
time appears to be a more useful indicator of increased
risk of infection than the actual levels of mHLA-DR
expression at given points in time. Patients in whom
recovery of mHLA-DR expression begins after days 1 and
2 are likely to have an uneventful outcome, whereas
those with persistently lower levels of mHLA-DR expres-
sion are more likely to suffer infection. Large, multicenter
studies are needed to confirm these promising results.
Key messages
￿ Severe trauma patients present with a transient
immunosuppression with decreased mHLA-DR
expression.
￿ The lack of mHLA-DR recovery between days 3
and 4 and days 1 and 2 is associated with sepsis.
￿ After adjustment for classic confounding risk fac-
tors, the lack of mHLA-DR recovery was the sole
factor independently and significantly associated
with the development of sepsis.
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